SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
05-Mar-24 4:13 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 04-Mar-24 | Option Exercise | 1,584 | -- | -- | 9% 16.83K to 18.41K | |
05-Mar-24 4:07 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 03-Mar-24 | Option Exercise | 3,667 | -- | -- | 18% 20.38K to 24.04K | |
05-Mar-24 4:06 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 03-Mar-24 | Option Exercise | 9,584 | -- | -- | 17% 57.85K to 67.43K | |
05-Mar-24 4:12 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 03-Mar-24 | Option Exercise | 3,667 | -- | -- | 11% 33.84K to 37.5K | |
05-Mar-24 4:06 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 12,917 | -- | -- | 29% 44.93K to 57.85K | |
05-Mar-24 4:13 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 3,667 | -- | -- | 28% 13.16K to 16.83K | |
05-Mar-24 4:12 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 5,500 | -- | -- | 19% 28.34K to 33.84K | |
05-Mar-24 4:07 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 02-Mar-24 | Option Exercise | 3,667 | -- | -- | 22% 16.71K to 20.38K | |
30-Jan-24 6:05 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 29-Jan-24 | Option Exercise | 792 | -- | -- | 6% 12.37K to 13.16K | |
30-Jan-24 6:04 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 28-Jan-24 | Option Exercise | 1,833 | -- | -- | 7% 26.5K to 28.34K | |
30-Jan-24 6:02 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 28-Jan-24 | Option Exercise | 4,792 | -- | -- | 12% 40.14K to 44.93K | |
10-Aug-23 4:10 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 273% 1.31K to 4.88K | |
10-Aug-23 4:05 PM View: | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 75% 4.77K to 8.34K | |
10-Aug-23 4:12 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 169% 2.11K to 5.68K | |
10-Aug-23 4:08 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 73% 4.9K to 8.47K | |
10-Aug-23 4:07 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 09-Aug-23 | Option Exercise | 3,571 | -- | -- | 273% 1.31K to 4.88K | |
10-Aug-23 8:44 AM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 08-Aug-23 | Option Exercise | 9,375 | -- | -- | 128% 7.33K to 16.71K | |
10-Aug-23 8:47 AM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 08-Aug-23 | Option Exercise | 6,945 | -- | -- | 128% 5.42K to 12.37K | |
10-Aug-23 8:41 AM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 08-Aug-23 | Option Exercise | 13,812 | -- | -- | 109% 12.69K to 26.5K | |
02-Jun-23 4:43 PM View: | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 7% 4.47K to 4.77K | |
02-Jun-23 4:44 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 16% 1.81K to 2.11K | |
02-Jun-23 4:41 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 6% 4.61K to 4.9K | |
02-Jun-23 4:48 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 29% 1.01K to 1.31K | |
02-Jun-23 4:46 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-23 | Option Exercise | 297 | -- | -- | 29% 1.01K to 1.31K | |
02-Jun-23 4:39 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 31-May-23 | Option Exercise | 1,834 | -- | -- | 33% 5.5K to 7.33K | |
07-Mar-23 10:00 PM View: | Taylor Daphne L SVP, CFO | Aptevo Therapeutics Inc. (APVO) | 04-Mar-23 | Option Exercise | 1,583 | -- | -- | 41% 3.84K to 5.42K | |
07-Mar-23 4:37 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 03-Mar-23 | Option Exercise | 9,582 | -- | -- | 31% 30.55K to 40.14K | |
07-Mar-23 4:44 PM View: | Lamothe Jeffrey G. EVP, COO | Aptevo Therapeutics Inc. (APVO) | 03-Mar-23 | Option Exercise | 3,666 | -- | -- | 41% 9.03K to 12.69K | |
07-Mar-23 4:42 PM View: | Kwon Soyoung SVP, GC, BD & Corp Affairs | Aptevo Therapeutics Inc. (APVO) | 03-Mar-23 | Option Exercise | 3,666 | -- | -- | 200% 1.83K to 5.5K | |
30-Jan-23 1:07 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 29-Jan-23 | Option Exercise | 4,791 | -- | -- | 19% 25.76K to 30.55K | |
30-Jan-23 1:04 PM View: | Lamothe Jeffrey G. CFO | Aptevo Therapeutics Inc. (APVO) | 29-Jan-23 | Option Exercise | 1,834 | -- | -- | 26% 7.19K to 9.03K | |
03-Jun-22 3:10 PM View: | Harsanyi Zsolt Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 7% 4.31K to 4.61K | |
03-Jun-22 2:56 PM View: | Grant Grady III Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 42% 0.71K to 1.01K | |
03-Jun-22 3:13 PM View: | Kwon Soyoung SVP, GC and Corporate Affairs | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 1,833 | -- | -- | 100% 0 to 1.83K | |
03-Jun-22 3:01 PM View: | Kunz Barbara Lopez Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 42% 0.71K to 1.01K | |
03-Jun-22 3:06 PM View: | Niederhuber John Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 13% 2.32K to 2.62K | |
03-Jun-22 3:16 PM View: | Abdun-Nabi Daniel Director | Aptevo Therapeutics Inc. (APVO) | 01-Jun-22 | Option Exercise | 298 | -- | -- | 4% 7.81K to 8.11K | |
01-Feb-22 6:00 PM View: | Lamothe Jeffrey G. SVP and CFO | Aptevo Therapeutics Inc. (APVO) | 29-Jan-22 | Option Exercise | 1,833 | -- | -- | 34% 5.36K to 7.19K | |
01-Feb-22 6:01 PM View: | White Marvin L President and CEO Director | Aptevo Therapeutics Inc. (APVO) | 29-Jan-22 | Option Exercise | 4,792 | -- | -- | 23% 20.97K to 25.76K | |
07-Dec-21 9:09 PM View: | El-Hibri Fuad Director | Aptevo Therapeutics Inc. (APVO) | 03-Dec-21 | Acquisition (other) | 124,999 | -- | -- | 156% 80.32K to 205.32K | |
26-Nov-21 1:02 PM View: | Tang Kevin C | Aptevo Therapeutics Inc. (APVO) | 23-Nov-21 | Market Sale | 921,336 | $11.25 | $10,368,200.00 | (100%) 921.34K to 0 | (6%) |
22-Nov-21 5:26 PM View: | Tang Kevin C 10% Owner | Aptevo Therapeutics Inc. (APVO) | 22-Nov-21 | Market Sale | 255,331 | $7.03 | $1,795,990.00 | (22%) 1.18M to 921.34K | (4%) |
22-Nov-21 5:26 PM View: | Tang Kevin C 10% Owner | Aptevo Therapeutics Inc. (APVO) | 19-Nov-21 | Market Sale | 213,800 | $7.59 | $1,622,870.00 | (15%) 1.39M to 1.18M | 4% |
22-Nov-21 5:26 PM View: | Tang Kevin C 10% Owner | Aptevo Therapeutics Inc. (APVO) | 18-Nov-21 | Market Sale | 369,533 | $8.34 | $3,081,560.00 | (21%) 1.76M to 1.39M | 12% |
06-Nov-20 4:47 PM View: | Tang Kevin C 10% Owner | Aptevo Therapeutics Inc. (APVO) | 06-Nov-20 | Market Purchase | 174,277 | $22.73 | $3,961,900.00 | 11% 1.59M to 1.76M | |
06-Nov-20 4:47 PM View: | Tang Kevin C 10% Owner | Aptevo Therapeutics Inc. (APVO) | 05-Nov-20 | Market Purchase | 625,723 | $18.78 | $11,750,300.00 | 65% 960.0K to 1.59M | |
06-Nov-20 4:47 PM View: | Tang Kevin C 10% Owner | Aptevo Therapeutics Inc. (APVO) | 04-Nov-20 | Market Purchase | 636,675 | $14.35 | $9,137,030.00 | 197% 323.32K to 960.0K | |
19-Aug-19 8:29 AM View: | Maddux Randy Joe SVP Operations, CMO | Aptevo Therapeutics Inc. (APVO) | 16-Aug-19 | Market Purchase | 25,000 | $0.76 | $19,000.00 | 50% 50.0K to 75.0K | |
13-Aug-19 9:46 PM View: | El-Hibri Fuad Director | Aptevo Therapeutics Inc. (APVO) | 12-Aug-19 | Market Purchase (Planned) | 100,000 | $0.76 | $75,520.00 | 3% 3.96M to 4.06M | |
30-Jul-19 6:49 PM View: | El-Hibri Fuad Board of Directors Director 10% Owner | Aptevo Therapeutics Inc. (APVO) | 29-Jul-19 | Market Purchase | 55,015 | $0.83 | $45,860.50 | 6% 969.52K to 1.02M | 4179% |